Hodgkin’s disease in elderly patients (≥60): Clinical outcome and treatment strategies
Authors:
- H.KAtherine KimHKH.KAtherine Kim
- Barbara SilverBSBarbara Silver
- Sigui LiSLSigui Li
- Donna NeubergDNDonna Neuberg
- Peter MauchPMPeter Mauch
- 1 June 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 56 (2) , 556-560
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-Term Survival and Competing Causes of Death in Patients With Early-Stage Hodgkin’s Disease Treated at Age 50 or YoungerJournal of Clinical Oncology, 2002
- Hodgkin's Disease in the Elderly: Improved Treatment Outcome With a Doxorubicin-Containing RegimenJournal of Clinical Oncology, 2002
- Efficacy and toxicity of vinblastine, bleomycin, and methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study.Journal of Clinical Oncology, 1994
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDNew England Journal of Medicine, 1992
- Hodgkin's disease and age*European Journal of Haematology, 1989
- Ch1VPP—An Effective and Well-Tolerated Alternative to MOPP Therapy for Hodgkinʼs DiseaseAmerican Journal of Clinical Oncology, 1988
- A multivariate analysis of prognostic factors in early stage hodgkin's diseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- Hodgkin's Disease in Patients Over Sixty Years OldAnnals of Internal Medicine, 1984
- Hodgkin’s Disease in the ElderlyOncology, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958